Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds

Title
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds
Authors
Keywords
Physical Function, Clinical Endpoint, Visual Analogue Scale Pain, Fatigue Score, Patient Global Assessment
Journal
Health and Quality of Life Outcomes
Volume 12, Issue 1, Pages 31
Publisher
Springer Nature
Online
2014-03-05
DOI
10.1186/1477-7525-12-31

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started